Latest Diabetes: Type II news
Diabetes Remission Increased With Dapagliflozin Plus Calorie Restriction
posted January 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Semaglutide Doubles Risk for Nonarteritic Anterior Ischemic Optic Neuropathy
posted January 14th
by modernClinician Editorial Team
by modernClinician Editorial Team
Study Quantifies Global T2DM, CVD Burdens Attributable to Sugary Drinks
posted January 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves First Generic Liraglutide Once-Daily Injection
posted December 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD 
Type 2 Diabetes Linked to Worse Menopausal Symptoms .jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk Related Articles
AHA: Consuming Up to 400 mg/Day of Caffeine Safe for Most Adults 
GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy 
GLP-1 Receptor Agonists Linked to Lower Mortality, Amputation Rate in PAD and Type 2 Diabetes Monthly Specialist Briefings
Stay Connected
